Takeda Pharmaceutical Company Limited Share Price NYSE
Stocks
TAK
US8740602052
Pharmaceuticals
OTC Markets Traded|
Market Closed -
NYSE
21:00:03 06/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 21.02 USD | -0.80% |
|
+0.53% | +34.83% |
| Market Cap | 10,479B 66.18B 59.36B 54.25B 49.52B 93.3B 6,221B 96.24B 654B 261B 3,319B 248B 243B | P/E 2027 * |
47.5x | P/E 2028 * | 32.6x |
|---|---|---|---|---|---|
| Enterprise Value | 14,433B 91.15B 81.75B 74.71B 68.2B 128B 8,568B 133B 901B 359B 4,572B 342B 335B | EV / Sales 2027 * |
3.07x | EV / Sales 2028 * | 2.95x |
| Free-Float |
99.18% | Yield 2027 * |
3.11% | Yield 2028 * | 3.18% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| TAK | Delayed | |
CBOE
| TAK | Real-time | |
|
London S.E.
| 0A87 | Delayed | |
|
Mexican S.E.
| TAK N | End-of-day quote | |
|
Deutsche Boerse AG
| TKDA | Delayed | |
|
Börse Stuttgart
| TKDA | Delayed | |
|
Tradegate
| TKDA | Real-time | |
|
Boerse Muenchen
| TKDA | Real-time |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -0.80% | ||
| 1 week | +0.53% | ||
| Current month | +0.53% | ||
| 1 month | +16.13% | ||
| 3 months | +23.50% | ||
| 6 months | +25.72% | ||
| Current year | +34.83% |
| 1 week | 20.57 |  | 21.72 |
| 1 month | 18.14 | | 21.72 |
| Current year | 14.84 | | 21.72 |
| 1 year | 13.56 | | 21.72 |
| 3 years | 12.58 | | 21.72 |
| 5 years | 12.28 | | 21.72 |
| 10 years | 12.28 | | 31.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/2024 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 31/03/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 48 | 31/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 61 | 31/05/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 31/12/2018 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 31/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.80% | +0.53% | - | - | 69.67B | |
| -0.79% | -4.48% | +44.44% | +127.49% | 1,216B | |
| +1.43% | +1.11% | +47.73% | +82.08% | 656B | |
| +1.07% | -1.21% | +32.99% | +106.31% | 509B | |
| -0.36% | -3.25% | +47.17% | +64.58% | 384B | |
| -0.14% | -1.87% | +71.05% | +40.63% | 362B | |
| -0.78% | -0.52% | +30.57% | +57.98% | 311B | |
| -0.80% | +6.73% | +11.89% | +35.64% | 293B | |
| +0.03% | -1.20% | +45.89% | +68.76% | 249B | |
| -0.41% | -2.22% | +35.24% | +105.68% | 208B | |
| Average | -0.30% | +0.60% | +40.78% | +76.57% | 465.31B | |
| Weighted average by Cap. | -0.24% | +0.03% | +42.43% | +88.36% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,706B 29.72B 26.66B 24.36B 22.24B 41.9B 2,794B 43.22B 294B 117B 1,491B 112B 109B | 4,813B 30.4B 27.26B 24.92B 22.75B 42.86B 2,858B 44.21B 300B 120B 1,525B 114B 112B |
| Net income | 209B 1.32B 1.18B 1.08B 988M 1.86B 124B 1.92B 13.04B 5.2B 66.21B 4.95B 4.85B | 338B 2.13B 1.91B 1.75B 1.6B 3.01B 201B 3.1B 21.08B 8.41B 107B 8.01B 7.84B |
| Net Debt | 3,954B 24.97B 22.39B 20.47B 18.68B 35.2B 2,347B 36.31B 247B 98.37B 1,252B 93.72B 91.71B | 3,727B 23.54B 21.11B 19.29B 17.61B 33.18B 2,212B 34.23B 233B 92.73B 1,181B 88.34B 86.45B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | US$21.02 | -0.80% | 2,965,879 |
| 05/11/26 | US$21.19 | +0.62% | 4,735,016 |
| 04/11/26 | US$21.06 | +1.49% | 2,975,730 |
| 03/11/26 | US$20.75 | -0.57% | 2,575,640 |
| 02/11/26 | US$20.87 | -0.19% | 2,650,794 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
- TAK Stock
Select your edition
All financial news and data tailored to specific country editions
